| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |